| The company operates an EMI qualifying share option scheme and during the year the company granted 253,062 EMI qualifying share options to employees of the company (2021: 2,516,219). At the statement of financial position date, the company had granted a total of 2,769,281 EMI qualifying share options to employees with an average weighted exercise price £0.43 per share. As at the year end date; 1,654,250 share options had vested (2021: 1,176,471), 481,202 share options had lapsed (2021: 125,766), 633,829 share options had yet to vest (2021: 1,213,982). The EMI qualifying share options vest over a 4 year period and are exercisable on the share capital of the company.
The company also operates an unapproved share option scheme and during the year the company granted 0 unapproved share options to employees and advisers of the company (2021: 59,404). At the statement of financial position date, the company had granted a total of 59,404 unapproved share options to employees with an average weighted exercise price £0.43 per share. As at the year end date; 18,564 unapproved share options had vested (2021: 0), 0 unapproved share options had lapsed (2021: 0), 40,840 unapproved share options had yet to vest (2021: 59,404). The unapproved share options vest over a 4 year period and are exercisable on the share capital of the company.
At the statement of financial position date the fair value of the granted share options was deemed immaterial to the financial statements, therefore no amount has been recognised in the income statement in respect of either of the above share option schemes. |